People of color historically have been more likely to be uninsured and to face more barriers accessing care than Whites. The Affordable Care Act (ACA) health coverage expansions provided an opportunity to help reduce these disparities. This brief examines changes in health coverage since the implementation of the ACA by race and ethnicity and discusses the implications for health coverage disparities.
- view as grid
- view as list
Section 1115 Medicaid demonstration waivers provide states an avenue to test new approaches in Medicaid that differ from federal program rules. Waivers can provide states considerable flexibility in how they operate their programs, beyond what is available under current law. While there is great diversity in how states have used waivers over time, waivers generally reflect priorities identified by states and the Centers for Medicare and Medicaid Services (CMS). This brief answers basic questions about Section 1115 waiver authority and discusses the current landscape of approved and pending demonstration waivers.
Following President Trump’s Feb. 5 State of the Union announcement of a commitment to end HIV in the United States by 2030, KFF’s Tina Hoff answers three questions about HIV in America today and lessons learned through KFF’s Greater Than AIDS campaigns.
This fact sheet examines the key role played by the United States in the Global Fund, an independent, multilateral financing entity designed to raise significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
This updated fact sheet highlights the epidemic’s impact on Black Americans, providing current data and trends over time. Black Americans have been disproportionately affected by HIV/AIDS since the epidemic’s beginning, and that disparity has deepened over time. Blacks account for more new HIV diagnoses, people estimated to be living with HIV, and HIV-related deaths than any other racial/ethnic group in the U.S.
This primer provides basic information about global health and U.S. government programs that address global health. The first several sections provide an overview of the field of global health and describe current global health issues. The subsequent sections describe U.S. government support for global health, from the programs the government supports, to the organization of the U.S. response, the budgets and financing of U.S. global health programs, and the U.S. government’s relationship with multilateral institutions and international partners.
This fact sheet provides an overview of the Ryan White Program, the largest HIV-specific federal grant program in the United States.
This updated fact sheet provides the latest data on the U.S. HIV epidemic, including key trends over time, impact by region and population, and information on the U.S. government’s response.
Medicare Part D has helped to make prescription drugs more affordable for people with Medicare, yet many beneficiaries continue to face high out-of-pocket costs for their medications. Specialty tier drugs are a particular concern for Part D enrollees in this context. This analysis draws on data from Medicare’s Plan Finder website to calculate expected annual 2019 out-of-pocket costs for 30 specialty tier drugs used to treat four health conditions—cancer, hepatitis C, multiple sclerosis, and rheumatoid arthritis.
A new issue brief looks at long-term trends in employer-based health insurance coverage, and finds that although the share of nonelderly Americans with employer-based health insurance has risen modestly in recent years, the long-term trend still shows a decline. If coverage rates had stayed at the 1999 level (67.3%), almost 24…